As of 2024-12-13, the Intrinsic Value of Surgery Partners Inc (SGRY) is
41.72 USD. This SGRY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 20.25 USD, the upside of Surgery Partners Inc is
106.00%.
The range of the Intrinsic Value is 27.06 - 70.59 USD
41.72 USD
Intrinsic Value
SGRY Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
27.06 - 70.59 |
41.72 |
106.0% |
| DCF (Growth 10y) |
37.71 - 83.85 |
53.35 |
163.5% |
| DCF (EBITDA 5y) |
18.65 - 29.56 |
22.20 |
9.6% |
| DCF (EBITDA 10y) |
29.90 - 43.73 |
34.83 |
72.0% |
| Fair Value |
-11.92 - -11.92 |
-11.92 |
-158.86% |
| P/E |
(6.94) - 30.72 |
9.36 |
-53.8% |
| EV/EBITDA |
8.79 - 24.64 |
17.09 |
-15.6% |
| EPV |
12.39 - 19.44 |
15.92 |
-21.4% |
| DDM - Stable |
(3.21) - (8.13) |
(5.67) |
-128.0% |
| DDM - Multi |
15.55 - 30.99 |
20.76 |
2.5% |
SGRY Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,573.98 |
| Beta |
1.50 |
| Outstanding shares (mil) |
127.11 |
| Enterprise Value (mil) |
5,543.68 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.83% |
| Cost of Debt |
7.08% |
| WACC |
8.35% |